Skip to main content

Table 5 Progression-free survival

From: The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

  Low Intermediate High
Months % Alive No. at Risk % Alive No. at Risk % Alive No. at Risk
0 100% 17 100% 70 100% 66
12 29% 5 27% 19 23% 15
24 12% 2 11% 8 6% 4
36 12% 2 4% 2 0 0
48 12% 1 0 0 0 0
60 12% 1 0 0 0 0
Median Dead/Total 9.9 mo. 16/17 7.2 mo. 69/70 5.8 mo. 66/66
  1. Pairwise Comparisons using Log-rank test: Low vs. Intermediate (0.2), Low vs. High (0.08), Intermediate vs. High (0.31).